MedTrace Logo

Thermal Pulsation Versus Warm Compress Treatment for Meibomian Gland Dysfunction

NCT06326931 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-03-22

No results posted yet for this study

Summary

This study aimed to assess the treatment outcome differences between a single, in-office bilateral treatment with the thermal pulsation system and twice-daily, 10-minute applications of the warm compress mask at home for 8 weeks.

Conditions

  • Meibomian Gland Dysfunction

Interventions

DEVICE

thermal pulsation

Single, in-office bilateral treatment with Systane iLux thermal pulsation

OTHER

warm compress

Twice daily, 10-minute at-home treatment with Bruder warm compress mask for 8 weeks

Sponsors & Collaborators

  • Jacksoneye

    lead OTHER

Principal Investigators

  • Melissa Bollinger, OD, FAAO · Jacksoneye

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-24
Primary Completion
2023-06-22
Completion
2023-06-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06326931 on ClinicalTrials.gov